Taking drugs the wrong way

  • August 8, 2013
Taking drugs the wrong way

40% of patients with heart problems take drugs incorrectly, according to a major study.

The study, just published in the European Heart Journal, was led by Gates Cambridge Scholar Dr Rajiv Chowdhury [2009] and Gates Cambridge Alumnus Dr Hassan Khan [2009].

Based on worldwide participant data from ~2 Million individuals, the study showed that 40% of people do not adhere adequately to cardiovascular medications and that this applies to all individual drug classes. The research also shows that a considerable proportion of all cardiovascular events (around 9% in Europe) can be attributed to poor adherence to vascular medications alone and that taking the drugs as prescribed significantly prevents adverse outcomes.

The researchers say measures to enhance adherence are urgently required so that patients get the maximum benefit from their medication.

The study was done in collaboration with the researchers from World Health Organisation and Erasmus University in the Netherlands.

The authors say several factors may contribute to the low levels of good adherence to cardiovascular medications observed among the participants of the studies that they reviewed. These include low social status, low health literacy, the existence of other chronic conditions and the use of other drugs.

 

Image: Jomphong from http://www.freedigitalphotos.net.

Latest News

Towards a dictionary of the human genome

Marie Brunet’s research focuses on the secrets still hidden in our genomes. She says that despite the fact that we live in an era where getting our genome sequenced is possible, we still don’t know the origin of two fifths of inherited diseases. That is because, as she says, the genome only currently maps the […]

Scholar recognised for research into misinformation

A Gates Cambridge Scholar has been shortlisted for a Women of the Future Award for her research into countering misinformation. Melisa Basol [2018] was shortlisted for the science category of the UK Awards which recognises “truly remarkable female scientists, forging new ground in research and scientific achievement”. There are 11 other categories and three special […]

Scholars join forces on anti-cancer drug

Two Gates Cambridge Scholars have joined forces to work on a drug candidate that has the potential to replace one of the most widely used cancer drugs around the world. Dr Anand Jeyasekharan [2004], who did his PhD in Oncology, and Dr Chandler Robinson [2009] who did an MBA at Cambridge, will collaborate on a […]

Making the experiences of imprisoned women activists visible

Growing up in a small town in Bengal, Jigisha Bhattacharya [2022] developed a particular sensitivity to marginalised groups and conflicts between different communities and identities from an early age.  It is this interest and her experience of political protests at university, combined with a longstanding curiosity about the links between politics and the arts, that […]